Surface-enhanced Raman spectroscopy (SERS) is revolutionizing biomedical diagnostics and therapeutics, enabling breakthroughs ...

New data from US centers suggest some overtesting in patients without chest pain, and undertesting in those who do.

Cardiac enzymes ― also known as cardiac biomarkers ― include myoglobin, troponin and creatine kinase. Historically, lactate dehydrogenase, or LDH, was also used but is non-specific.

The global cardiac biomarkers testing market size was valued at $9,766.93 million in 2020, and is projected to reach $28,098.07 million by 2030, registering a CAGR of 10.9% from 2021 to 2030. Cardiac ...

Rising Cardiovascular Disease Prevalence and Advancements in Diagnostic Technologies Propel Market GrowthPune, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Cardiac Biomarker Testing Market Size & Growth Analysis ...

Blood CK-MB may be derived from tissues other than cardiomyocytes and have lower specificity for cardiac tissue than troponins. However, in a recent study including 19 non-ST elevation OHCA ...

Cardiac biomarkers are used as first-line diagnostic tools in suspected myocardial injury and heart failure in adult patients. Their use in paediatric patients has been limited by variability caused ...

In this issue of the journal, Song et al 8 report on the influence of periprocedural elevations in cardiac biomarkers on 5-year cardiovascular mortality among patients undergoing coronary ...

The following is a summary of “Prognostic role of cardiac and inflammatory biomarkers in extubation failure in patients with COVID-19 acute respiratory distress syndrome,” published in the January ...

Pune, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Cardiac Biomarker Testing Market Size & Growth Analysis: “According to SNS Insider, The Cardiac Biomarker Testing Market size was valued at USD 4.53 ...